Designates Xylazine as a schedule III depressant in New York.
This bill amends the public health law to classify Xylazine as a schedule III depressant. This change includes Xylazine's salts, isomers, and salts of isomers. The bill will take effect 90 days after it becomes law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.